ANI Pharmaceuticals 对比 Collegium Pharmaceutical
可添加、更换或移除公司，最多四家。
简而言之
- ANI Pharmaceuticals 规模更大:2025 财年营收 $883M，Collegium Pharmaceutical 为 $781M。
- ANI Pharmaceuticals 营收增长更快(43.8%，对方为 23.6%)。
- Collegium Pharmaceutical 每一美元销售额中留下的营业利润更多(营业利润率 23.0%，对方为 12.6%)。
- Collegium Pharmaceutical 将更多销售额转化为自由现金流(自由现金流利润率 42.0%，对方为 19.4%)。
- Collegium Pharmaceutical 的投入资本回报更高(53.4%，对方为 15.9%)。
- 投资者愿为 Collegium Pharmaceutical 每一美元的盈利支付更高价格：市盈率 18.5x，而 ANI Pharmaceuticals 为 15.7x。
| 最近财年 | ANIP · FY25 | COLL · FY25 |
|---|---|---|
| 规模 | ||
| 市值 | $1.6B | $746M |
| 营收 | $883M | $781M |
| 自由现金流 | $171M | $328M |
| 净利润 | $78.3M | $62.9M |
| 增长 | ||
| 营收增长 | 43.8% | 23.6% |
| 5年增长率 | 33.5% | 20.3% |
| 股数变化 | 9.9% | −1.8% |
| 盈利能力 | ||
| 毛利率 | — | 59.4% |
| 营业利润率 | 12.6% | 23.0% |
| 净利率 | 8.9% | 8.1% |
| 自由现金流利润率 | 19.4% | 42.0% |
| 资本回报率 | 15.9% | 53.4% |
| 股本回报率 | 16.6% | 23.7% |
| 资产负债表 | ||
| 净债务 | $23.7M | −$149M |
| 净债务 / EBITDA | 0.1x | −0.4x |
| 股息与回购 | $13.4M | $25.1M |
| 估值与质量 | ||
| 市盈率 | 15.7x | 18.5x |
| Piotroski F 分数 | 6 | 6 |
FY16
ANIP $129M
COLL $1.7M
FY17
ANIP $177M
COLL $28.5M
FY18
ANIP $202M
COLL $280M
FY19
ANIP $207M
COLL $297M
FY20
ANIP $209M
COLL $310M
FY21
ANIP $216M
COLL $277M
FY22
ANIP $316M
COLL $464M
FY23
ANIP $487M
COLL $567M
FY24
ANIP $614M
COLL $631M
FY25
ANIP $883M
COLL $781M
ANIP
COLL
FY16
ANIP 15.6%
COLL −5,498.7%
FY17
ANIP 16.0%
COLL −265.0%
FY18
ANIP 17.5%
COLL −7.4%
FY19
ANIP 7.9%
COLL −8.0%
FY20
ANIP −7.7%
COLL 18.1%
FY21
ANIP −18.4%
COLL 6.4%
FY22
ANIP −11.2%
COLL 7.2%
FY23
ANIP 9.7%
COLL 29.5%
FY24
ANIP 0.1%
COLL 26.9%
FY25
ANIP 12.6%
COLL 23.0%
ANIP
COLL
FY16
ANIP $22.9M
COLL −$75.5M
FY17
ANIP $29.1M
COLL −$68.0M
FY18
ANIP $61.3M
COLL $164M
FY19
ANIP $39.0M
COLL $21.3M
FY20
ANIP $9.1M
COLL $88.4M
FY21
ANIP $0.8M
COLL $102M
FY22
ANIP −$40.1M
COLL $123M
FY23
ANIP $110M
COLL $274M
FY24
ANIP $47.8M
COLL $203M
FY25
ANIP $171M
COLL $328M
ANIP
COLL
FY16
ANIP 5.3%
COLL —
FY17
ANIP 5.3%
COLL —
FY18
ANIP 11.0%
COLL —
FY19
ANIP 5.8%
COLL —
FY20
ANIP −3.6%
COLL —
FY21
ANIP −7.0%
COLL 10.4%
FY22
ANIP −5.2%
COLL 16.5%
FY23
ANIP 8.5%
COLL 68.7%
FY24
ANIP 0.1%
COLL 53.0%
FY25
ANIP 15.9%
COLL 53.4%
ANIP
COLL
各公司最近一个财年的数据；各公司财年结束月份不同。在越高(或越低)明显越好的行中，突出显示最佳值。不构成投资建议。